Exploring the Effectiveness of AI Generative Models for Diabetic Patients
Recruiting
Observational Study
Diabetes Mellitus, Type 2
Diabetic Retinopathy
Diabetes
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 – 100
- Sex
- Any
- Study type
- Observational
- Participants needed
- 300 (estimated)
- Sponsor
- Pakistan Council of Scientific and Industrial Research · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
We plan to explore the usability of Generative AI-Chatbot for Diabetic Patient
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Present physically in Pakistan
* Adults (18 years or older)
* Diabetic Patient
Exclusion Criteria:
* Adults unable to consent
* Individuals who are not yet adults (infants, children, teenagers)
* Prisoners
Contacts